中文

Untranslated

English
Chinese
French
German
Portuguese
Spanish
Russian
Japanese
Korean
Arabic
Irish
Greek
Turkish
Italian
Danish
Romanian
Indonesian
Czech
Afrikaans
Swedish
Polish
Basque
Catalan
Esperanto
Hindi
Lao
Albanian
Amharic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Bulgarian
Cebuano
Chichewa
Corsican
Croatian
Dutch
Estonian
Filipino
Finnish
Frisian
Galician
Georgian
Gujarati
Haitian
Hausa
Hawaiian
Hebrew
Hmong
Hungarian
Icelandic
Igbo
Javanese
Kannada
Kazakh
Khmer
Kurdish
Kyrgyz
Latin
Latvian
Lithuanian
Luxembou..
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Burmese
Nepali
Norwegian
Pashto
Persian
Punjabi
Serbian
Sesotho
Sinhala
Slovak
Slovenian
Somali
Samoan
Scots Gaelic
Shona
Sindhi
Sundanese
Swahili
Tajik
Tamil
Telugu
Thai
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Kinyarwanda
Tatar
Oriya
Turkmen
Uyghur

More Language

86-21-64556180

cpd-service@caerulumpharma.com

Ekhaya
Ngathi
Iimveliso
Izisombululo
Izibonelelo
- Downloadable
- Igalari yomfanekiso
Ii-FAQs
Qhagamshelana nathi

Ekhaya
Iimveliso
Iimolekyuli zeBioactive
I-Antineoplastic
I-BCl2-BH4

Iintlobo zeemveliso

I-Antineoplastic
- I-ACC
- Adenosine A2A
- I-ALK
- I-Androgen receptor inhibitor
- I-Apoptosis evuselelayo
- ATR
- AXL
- I-BCl2-BH4
- Bcr-Abl
- I-BRAF
- I-BTK
- CDK
- Khk1
- I-CYP17
- DNA alkylating agent
- EED
- EGFR
- EP4
- ER
- FAK
- FGFR
- FLT3
- Glutaminase
- NDIYAVUMA
- I-IRA
- IKIT
- LXR
- MDM2
- MEK
- YAMET
- Nrf2
- P90RSK
- P97
- I-PAKS
- I-PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Iziyobisi ze-Hypoglycemic
Abanye
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- FXR
- GABA
- Gi activator
- GR
- JAK
- LABA
- iimachRs
- NF-kB
- I-NRTI
- PPAR
- RIP1
- I-S1PR
- SGC
- SYK
- α2δ-1
- αIIbβ3
- β2-adrenoceptor
- σ1

I-BCl2-BH4

CAT #	Igama lemveliso	Inkcazo
CPD102300	S-55746

Qhagamshelana nathi

No. 401, 4th Floor, Building 6, Quwu Road 589, Minhang District, 200241 Shanghai, China
86-21-64556180
ETshayina:
sales-cpd@caerulumpharma.com
Amazwe ngamazwe:
cpd-service@caerulumpharma.com

Ukubuza

Ngemibuzo malunga neemveliso zethu, nceda ushiye i-imeyile yakho kunye nathi kwaye siya kuqhagamshelana phakathi kweeyure ezingama-24.Ukubuza

Iindaba zamva

I-AstraZeneca ifumana unyuso lolawulo lwamachiza e-oncology

I-AstraZeneca ifumana unyuso lolawulo lwe...

I-AstraZeneca ifumene ukongezwa okuphindwe kabini kwipotfoliyo yayo ye-oncology ngoLwesibini, emva kokuba abalawuli base-US naseYurophu bamkele ukungeniswa kolawulo lwamachiza ayo, inyathelo lokuqala lokuphumelela ukuvunywa kwala mayeza. ...

Iindlela eziPhezulu ze-7 kuPhando lwezoPhando kwi-2018

IiNdlela ezi-7 eziphambili kuPhando lwaMayeza...

Ukuba phantsi koxinzelelo oluhlala lukhula lokukhuphisana kwimeko yezoqoqosho kunye nethekhinoloji ecela umngeni, iinkampani zamayeza kunye nebhayoloji kufuneka ziqhubeke zenza izinto ezintsha kwiinkqubo zazo zeR&D ukuze zihlale phambili ...

I-ARS-1620: I-inhibitor entsha ethembisayo ye-KRAS-mutant cancers

I-ARS-1620: Isithinteli esitsha esithembisayo se-K...

Ngokophononongo olupapashwe kwiSeli, abaphandi baye baphuhlisa inhibitor ethile ye-KRASG12C ebizwa ngokuba yi-ARS-1602 ebangele ukuhlehla kwethumba kwiimpuku. "Olu phononongo lubonelela ngobungqina bokuba i-KRAS eguqukayo inokuba...

I-AstraZeneca ifumana unyuso lolawulo lwe...

I-AstraZeneca ifumene ukongezwa okuphindwe kabini kwipotfoliyo yayo ye-oncology ngoLwesibini, emva kokuba abalawuli base-US naseYurophu bamkele ukungeniswa kolawulo lwamachiza ayo, inyathelo lokuqala lokuphumelela ukuvunywa kwala mayeza. ...

IiNdlela ezi-7 eziphambili kuPhando lwaMayeza...

Ukuba phantsi koxinzelelo oluhlala lukhula lokukhuphisana kwimeko yezoqoqosho kunye nethekhinoloji ecela umngeni, iinkampani zamayeza kunye nebhayoloji kufuneka ziqhubeke zenza izinto ezintsha kwiinkqubo zazo zeR&D ukuze zihlale phambili ...

Ii-FAQs
Downloadable
Qhagamshelana nathi

Thumela i-imeyile

Ikhowudi yeQR

x

Incoko ka-WhatsApp kwi-Intanethi!

TOP

Close

Previous Next

Previous Maximize